Physician profile
Kyle Johnson
NPI 1275824419
$2,205.23
in general payments reported to CMS, 2019-2025
10 companies · $24.48 in 2025
The $24.48 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $996 · 2020: $64.14 · 2021: $19.89 · 2022: $138 · 2023: $141 · 2024: $823 · 2025: $24.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540 · Travel and Lodging: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.15 |
| Travel and Lodging | $447.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $756.94 | 2019-2024 | Mtp, Portfolio |
| Medtronic Vascular, INC. | $277.60 | 2019 | |
| Depuy Synthes Sales INC. | $261.31 | 2022-2024 | Motoband, Na, Hammerlock |
| Stryker Corporation | $211.76 | 2019-2024 | Prostep Mica |
| Osiris Therapeutics INC. | $206.61 | 2019 | |
| Organogenesis INC. | $175.96 | 2019-2022 | |
| Wright Medical Technology, INC. | $142.72 | 2019 | |
| Merck Sharp & Dohme LLC | $108.97 | 2019 | |
| Coastal Medical Technologies LLC | $47.74 | 2023-2025 | |
| Zyla Life Sciences, INC. | $15.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.